Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis

  1. Cortes, J.
  2. Haiderali, A.
  3. Huang, M.
  4. Pan, W.
  5. Schmid, P.
  6. Akers, K.G.
  7. Park, J.E.
  8. Frederickson, A.M.
  9. Fasching, P.A.
  10. O’Shaughnessy, J.
Revue:
BMC Cancer

ISSN: 1471-2407

Année de publication: 2023

Volumen: 23

Número: 1

Type: Article

DOI: 10.1186/S12885-023-11293-4 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus